First Time Loading...
K

Kidswell Bio Corporation
TSE:4584

Watchlist Manager
Kidswell Bio Corporation
TSE:4584
Watchlist
Price: 132 JPY -5.71% Market Closed
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

5.2B
+63%
Assets
Growth Rates:
1 Year
+25%
3 Years
+42%
5 Years
+80%
7 Years
+37%
10 Years
+151%
3.8B
+77%
Liabilities
Growth Rates:
1 Year
+51%
3 Years
+74%
5 Years
+1 256%
7 Years
+903%
10 Years
+201%
1.4B
+34%
Equity
Growth Rates:
1 Year
-14%
3 Years
-5%
5 Years
-45%
7 Years
-58%
10 Years
+75%

Balance Sheet Decomposition
Kidswell Bio Corporation

5.2B
Assets
3.8B
Liabilities
5.2B
Assets
3.8B
Liabilities
Current Assets 5B
Cash & Short-Term Investments 2.2B
Receivables 481.9m
Other Current Assets 2.4B
Non-Current Assets 161.7m
PP&E 1.4m
Intangibles 1.7m
Other Non-Current Assets 158.6m
Current Liabilities 2B
Accounts Payable 72.3m
Other Current Liabilities 1.9B
Non-Current Liabilities 1.8B
Long-Term Debt 1.7B
Other Non-Current Liabilities 41.6m

Balance Sheet
Kidswell Bio Corporation

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
1 610
599
817
2 380
1 891
2 009
2 033
1 461
1 187
1 067
Cash Equivalents
1 610
599
817
2 380
1 891
2 009
2 033
1 461
1 187
1 067
Total Receivables
149
190
199
587
405
559
652
817
462
1 089
Accounts Receivables
149
190
199
587
405
559
652
817
462
1 089
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
12
254
451
989
635
Other Current Assets
123
303
504
455
396
241
384
618
688
906
Total Current Assets
1 882
1 092
1 520
3 422
2 692
2 822
3 322
3 346
3 326
3 697
PP&E Net
1
0
2
2
2
1
2
3
2
1
PP&E Gross
1
0
2
2
2
1
2
3
2
1
Accumulated Depreciation
6
5
5
6
6
6
121
11
12
7
Intangible Assets
0
0
0
0
0
0
0
3
3
2
Long-Term Investments
0
50
165
276
325
323
249
563
155
173
Other Long-Term Assets
4
4
6
6
6
6
19
19
18
21
Total Assets
1 887
N/A
1 147
-39%
1 694
+48%
3 706
+119%
3 025
-18%
3 151
+4%
3 592
+14%
3 934
+10%
3 503
-11%
3 895
+11%
Liabilities
Accounts Payable
0
0
69
0
60
57
9
110
45
156
Accrued Liabilities
4
5
6
6
6
8
0
0
0
1
Short-Term Debt
0
0
460
0
0
0
25
0
0
0
Current Portion of Long-Term Debt
0
0
350
0
0
0
0
0
75
375
Other Current Liabilities
46
88
395
184
338
335
847
1 005
1 008
524
Total Current Liabilities
50
92
1 280
189
405
400
881
1 114
1 129
1 056
Long-Term Debt
775
775
0
0
0
0
1 200
1 100
625
1 575
Deferred Income Tax
0
0
0
2
1
1
0
89
0
0
Other Liabilities
9
9
11
15
15
19
24
20
31
30
Total Liabilities
834
N/A
876
+5%
1 291
+47%
206
-84%
421
+104%
420
0%
2 105
+401%
2 324
+10%
1 785
-23%
2 661
+49%
Equity
Common Stock
1 571
1 576
2 037
4 194
100
591
612
1 032
1 421
1 509
Retained Earnings
1 993
2 785
3 573
4 795
872
1 726
9 020
9 962
10 429
11 091
Additional Paid In Capital
1 475
1 480
1 940
4 098
3 373
3 864
9 917
10 338
10 727
10 815
Unrealized Security Profit/Loss
0
0
0
4
3
2
22
203
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
1 053
N/A
271
-74%
403
+49%
3 500
+768%
2 604
-26%
2 731
+5%
1 487
-46%
1 610
+8%
1 719
+7%
1 234
-28%
Total Liabilities & Equity
1 887
N/A
1 147
-39%
1 694
+48%
3 706
+119%
3 025
-18%
3 151
+4%
3 592
+14%
3 934
+10%
3 503
-11%
3 895
+11%
Shares Outstanding
Common Shares Outstanding
10
10
12
19
19
20
28
30
31
32

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.